Shipra Joshi
-
Upload
techsci_research -
Category
Health & Medicine
-
view
7 -
download
0
description
Transcript of Shipra Joshi
-
MARKET INTELLIGENCE . CONSULTING
www.techsciresearch.com
2016 – 2026
ASIA PACIFIC CANCER DIAGNOSTICS MARKET
FORECAST & OPPORTUNITIES
-
2
Scope of ReportProduct of Interest (POI): Cancer Diagnostics
Review Period
2016 – 2019
Base Year
2020
Estimated Year
2021
Forecast Period
2022 – 2026
Year Range
CANCER DIAGNOSTICS MARKET
END USER TECHNOLOGY
• Platform based
• Instrument based
• Tumour biomarker
tests
APPLICATION
• Lung cancer
• Breast cancer
• Colorectal cancer
• Prostate cancer
• Kidney Cancer
• Skin cancer
• Others
• Diagnostic Centres
• Hospitals and
Clinics
• Research Institutes
• Others
Process of identification of cancer disease or condition from its signs and symptoms is knownas caner diagnostics. Cancer diagnostics involve methods such as lab testing, genetic testing,imaging testing, biomarkers testing, among others for the diagnosis of different kinds ofcancers.
Market Segmentation
DIAGNOSTIC TYPE
• Lab Testing
• Genetic Testing
• Imaging Testing
• Biomarkers Testing
• In Vitro Diagnostic Testing
• Biopsy
• OthersCOUNTRY
• China
• India
• Japan
• South Korea
• Australia
• Singapore
• Malaysia
• Indonesia
• Philippines
• Thailand
-
3
Table of Contents
S. No. Contents Page No.
1. Product Overview (Definition of product and major terminologies used in the report)
2.Research Methodology (Detailed description of the methodology used to conduct the research, Raw data backup, list of all secondary sources, List of respondents for primary surveys)
3. Executive Summary
4. Voice of Customer
5. Asia Pacific Cancer Diagnostics Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1.By Diagnostic Type (Lab Testing, Genetic Testing, Imaging Testing, Biomarkers Testing,In Vitro Diagnostic Testing, Biopsy and Others)
5.2.2. By Technology (Platform based, Instrument based, Tumour biomarker tests)
5.2.3.By Application (Lung cancer, Breast cancer, Colorectal cancer, Prostate cancer, KidneyCancer, Skin cancer, Others)
5.2.4. By End User (Diagnostic Centres, Hospitals and Clinics, Research Institutes and Others)
5.2.5. By Country
5.2.6. By Company (2020)
5.3. Product Market Map
6. China Cancer Diagnostics Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Diagnostic Type
-
4
Table of Contents
S. No. Contents Page No.
6.2.2. By Technology
6.2.3. By Application
6.2.4. By End User
7. India Cancer Diagnostics Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Diagnostic Type
7.2.2. By Technology
7.2.3. By Application
7.2.4. By End User
8. Japan Cancer Diagnostics Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Diagnostic Type
8.2.2. By Technology
8.2.3. By Application
8.2.4. By End User
9. South Korea Cancer Diagnostics Market Outlook
9.1. Market Size & Forecast
-
5
Table of Contents
S. No. Contents Page No.
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Diagnostic Type
9.2.2. By Technology
9.2.3. By Application
9.2.4. By End User
10. Australia Cancer Diagnostics Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Diagnostic Type
10.2.2. By Technology
10.2.3. By Application
10.2.4. By End User
11. Singapore Cancer Diagnostics Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Diagnostic Type
11.2.2. By Technology
11.2.3. By Application
11.2.4. By End User
12. Malaysia Cancer Diagnostics Market Outlook
-
6
Table of Contents
S. No. Contents Page No.
12.1. Market Size & Forecast
12.1.1. By Value
12.2. Market Share & Forecast
12.2.1. By Diagnostic Type
12.2.2. By Technology
12.2.3. By Application
12.2.4. By End User
13. Indonesia Cancer Diagnostics Market Outlook
13.1. Market Size & Forecast
13.1.1. By Value
13.2. Market Share & Forecast
13.2.1. By Diagnostic Type
13.2.2. By Technology
13.2.3. By Application
13.2.4. By End User
14. Philippines Cancer Diagnostics Market Outlook
14.1. Market Size & Forecast
14.1.1. By Value
14.2. Market Share & Forecast
14.2.1. By Diagnostic Type
14.2.2. By Technology
14.2.3. By Application
14.2.4. By End User
-
7
Table of Contents
S. No. Contents Page No.
15. Thailand Cancer Diagnostics Market Outlook
15.1. Market Size & Forecast
15.1.1. By Value
15.2. Market Share & Forecast
15.2.1. By Diagnostic Type
15.2.2. By Technology
15.2.3. By Application
15.2.4. By End User
16. Market Dynamics (This chapter assesses the major demand drivers and restraints.)
16.1. Drivers
16.2. Challenges
17.Market Trends & Developments (This section captures recent trends pertaining to manufacturing or consumption, market movements in terms of points of production and consumption, advancements and development)
18. Impact of COVID-19 on Asia Pacific Cancer Diagnostics Market
19. Market Trends & Developments
20. Competitive Landscape
20.1. Competition Outlook
20.2. Company Profiles (Leading Companies)
20.2.1. Company Details
20.2.2. Products & Services
20.2.3. Financials (As Reported)
20.2.4. Key Market Focus & Geographical Presence
20.2.5. Recent Developments
-
8
Table of Contents
S. No. Contents Page No.
20.2.6. Key Management Personnel
21.Strategic Recommendations (Based on the findings of the report strategic recommendations on how to enter and expand market share)
22. About Us & Disclaimer
-
RESEARCH METHODOLOGY
-
10
Research Methodology
✓ Identifying Key Opinion
Leaders
✓ Questionnaire Design
✓ In-depth Interviews
Data Collection
Developing list of respondents
Formulating Questionnaire
Market Profiling
Data Validation
Data Analysis
In-depth secondary research was conducted to
determine top players in the Asia Pacific cancer
diagnostics market, overall market size and segmental
market size.
In order to conduct industry experts’
interviews, TechSci formulated a detailed
discussion guide.
List of industry players and industry
specialists was developed.
TechSci conducted interviews with
industry experts and industry players for data collection and
verification.
Data obtained as a result of primary and secondary research was
validated through rigorous
triangulation.
The data was scrutinized using MS-Excel, statistical
tools and internal proprietary database to obtain qualitative and
quantitative insights about the Asia Pacific cancer
diagnostics market.
Data
Collection
Data Filter
& AnalysisResearch &
Intelligence
Actionable
InsightsBusiness
Solution
Primary Research Desk Research Company Analysis
✓ Recent Developments
✓ Market Changing
Aspects/Dynamics
✓ Government Policies
✓ Final Conclusion
✓ Market Participants
✓ Key Strengths
✓ LinkedIn✓ TechSci Internal
Database
✓ Factiva✓ Hoovers
Paid Sources
✓ Company Websites✓ Company Annual
Reports✓ White Paper Study✓ Financial Reports✓ Investor
Presentations✓ Regulatory Body✓ Associations, etc.
Secondary Research
Primary Research
-
11
Research Methodology
Baseline Methodology
Our dedicated team of industry experts has monitored and analyzed various aspects of Asia Pacific cancer diagnostics market. Anticipated growth in
the market can be attributed to growing demand for additive manufacturing. The team has analyzed the outlook of various segments of this market,
while considering the major influencing factors and speculated a positive growth during the next five years. The study includes market forecasting,
which would enable our clients to take better decisions while planning their strategy to achieve sustainability in Asia Pacific cancer diagnostics market.
Methodology Followed for Calculation of Market Size:
• Market Size by Value: Market size, in terms of value, for the year 2020 was calculated based on information collected through exhaustive
secondary research and primary surveys, with various key opinion leaders/stakeholders, such as cancer diagnostics companies, channel partners,
market influencers & end users, industry experts, and other industry participants.
• The team interviewed more than 15 – 20 cancer diagnostics companies, 45 – 50 channel partners, 80 – 100 end users, and 15 – 20 industry experts
and other value chain stakeholders in the Asia Pacific cancer diagnostics market to obtain the overall market size from 2016 to 2020, which was
validated by the Delphi technique. Taking standard deviation into consideration, the market size was averaged out, to arrive at the market size data
during 2016-2020.
• Respondents were asked about the current and future market growth rates, market shares by diagnostic type, by technology, by application, by end
user, by country and by company. Removing the outlier responses, the geometric mean of growth estimates and supplier wise revenue shares
generated across various segments were considered, to arrive at the final revenue shares.
-
12
Research Methodology
Revenue shares generated across various segments were further triangulated from other stakeholders.
Methodology Followed for Calculation of Market Shares:
Market shares by diagnostic type, by technology, by application, by end user, by country and by company were calculated based on the responses
received through primary surveys with industry experts, in which the respondents were asked about the market shares or revenue generated from
various segments of cancer diagnostics market. The final shares were calculated by taking the geometric mean of the responses gathered from key
opinion leaders after eliminating the outliers.
Methodology Followed for Forecasting:
• TechSci Research performed periodical checks on data collected through the surveys with logic checks and analyzed the survey results in
SPSS/Tableau Software.
• Data triangulation techniques were applied to fill the gaps and to present a more meaningful picture of the market. To forecast Asia Pacific cancer
diagnostics market, TechSci Research used various forecast techniques such as:
✓ Moving Average
✓ Time Series Analysis
✓ Regression Analysis
✓ Econometric and Judgmental Analysis
-
13
Research Methodology
TechSci Research used its own forecast tool, which is based on the growth of various allied industries in respective regions. TechSci Research also used
the impact analysis during short, medium and long term period to estimate the demand and to reach accurate market numbers. It should be noted that
the figures compiled are only for the organized market including market share data. The currency used in the report is the United States Dollar (USD),
with the market size indicated in USD million.
Partial List of Companies Interviewed Key Secondary Sources
▪ Thermo Fisher Scientific, Inc.
▪ GE Healthcare (A Subsidiary of General
Electric Company)
▪ Abbott Laboratories, Inc.
▪ Becton, Dickinson and Company
▪ Siemens AG
▪ Agilent Technologies, Inc.
▪ F. Hoffmann-La Roche Ltd.
▪ Bio Rad Laboratories Inc.
▪ Illumina, Inc.
▪ Boehringer-Ingelheim International GmbH
▪ World Bank
▪ TechSci Research Proprietary Database & Knowledge
Repository
▪ Company Annual Reports
▪ Industry Magazines
▪ Industry Reports
▪ News Dailies
▪ Credible Paid Databases
-
14
Industry Brief
According to TechSci Research report, “Asia-Pacific Cancer Diagnostics Market By Diagnostic Type (Lab Testing, Genetic Testing, Imaging
Testing, Biomarkers Testing, In Vitro Diagnostic Testing, Biopsy and Others), By Technology (Platform Based, Instrument Based, Tumour
Biomarker Tests), By Application (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Kidney Cancer, Skin cancer, Others), By
End-User (Diagnostic Centers, Hospitals and Clinics, Research Institutes and Others), By Region, Forecast & Opportunities, 2026”, the Asia-
Pacific cancer diagnostics market is expected to grow at a formidable CAGR during the forecast period on account of increasing trend of
unhealthy diet amongst population in the region. This in turn leads to increased count of patients suffering from diabetes and cancer, which is
expected to propel the market over the next five years. Furthermore, growing efforts undertaken by government to create awareness regarding
cancer, as well as to minimize the disease burden is anticipated to positively impact the growth of market through 2026. Surging demand for
screening tools and techniques is further spurring the growth of market. However, high cost of diagnosis might hamper the growth of market
during forecast period. Furthermore, several side effects associated with imaging solutions is expected to impede the growth of market over the
next few years.
The Asia-Pacific cancer diagnostics market is segmented based on diagnostic type, technology, application, end-user, company and region.
Based on diagnostic type, the market is categorized into lab testing, genetic testing, imaging testing, biomarkers testing, in vitro diagnostic
testing, biopsy and others. The imaging testing segment dominated the market until 2020 and is expected to dominate the market during forecast
period as well. This dominance can be ascribed to the fact that imaging modalities such as computed tomography scan and magnetic resonance
imaging are quick, non-invasive, and pain-free diagnostic solutions. In addition to this, technological advancements in imaging modalities have
contributed to the segment growth. Based on end-user, the market can be fragmented into diagnostic centers, hospitals and clinics, research
institutes and others. The hospitals and clinics segment is expected to dominate the market during the forecast period on account of increased
rates of adoption of technologically advanced imaging modalities and other devices which are used in the detection of cancer.
Thermo Fisher Scientific, Inc., GE Healthcare (A Subsidiary of General Electric Company), Abbott Laboratories, Inc., Becton, Dickinson and
Company, Siemens AG, Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., Bio Rad Laboratories Inc., Illumina, Inc., Boehringer-Ingelheim
International GmbH and others are some of the leading players operating in Asia-Pacific cancer diagnostics Market. The companies operating in
the market are using Go-to-Market strategies such as product launches, mergers and acquisitions and research collaborations to boost their
share.
“Asia-Pacific cancer diagnostics market is expected to witness high growth in the market during the forecast years owing to increasing healthcare
expenditure and presence of a large patient pool in the region. Additionally, thriving medical tourism industry in developing economies such as
India, China, and Malaysia is further anticipated to spur the market growth. Also, presence of large market players along with favorable
government policies supporting the growth of the manufacturing industry in the region is creating lucrative opportunities for the growth of cancer
diagnostics market in the upcoming years.”, said Mr. Karan Chechi, Research Director with TechSci Research, a research based global
management consulting firm.
-
15
Sample Data - Snapshot
5.00 6.007.00 8.00
9.00 10.0011.00 12.00
13.00 14.0015.00
2016 2020 2021E 2026F
By Value (USD Million)
Asia Pacific Cancer Diagnostics Market Size, By Value (USD Million), 2016–2026F
CAGR By Value
XX%CAGR By Value
YY%
15%
15%
15%
15%
15%
15%
15%
15%
15%
15%
15%
15%
15%
15%
15%
15%
15%
15%
15%
15%
15%
15%
15%
15%
15%
15%
15%
15%
15%
15%
15%
15%
15%
15%
15%
15%
15%
15%
15%
15%
15%
15%
15%
15%
15%
15%
15%
15%
15%
15%
15%
15%
15%
15%
15%
15%
15%
15%
15%
15%
15%
15%
15%
15%
15%
15%
10%
10%
10%
10%
10%
10%
10%
10%
10%
10%
10%
2016
2017
2018
2019
2020
2021E
2022F
2023F
2024F
2025F
2026F
Lab Testing Genetic Testing Imaging Testing Biomarkers Testing In Vitro Diagnostic Testing Biopsy Others
Singapore Cancer Diagnostics Market Share, By Diagnostic Type, By Value, 2016–2026F
30%
30%
30%
30%
30%
30%
30%
30%
30%
30%
30%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
30%
30%
30%
30%
30%
30%
30%
30%
30%
30%
30%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
2016
2017
2018
2019
2020
2021E
2022F
2023F
2024F
2025F
2026F
Diagnostic Centres Hospitals and Clinics Research Institutes Others
Singapore Cancer Diagnostics Market Share, By End User, By Value, 2016–2026F
-
16
Report Ordering
License Type Price
Electronic Access - Single User License $3950
Electronic Access - Multi-User License $4950
Custom Research License $8950
Report Price
To View Sample OR Purchase Report
Report Name: ASIA PACIFIC CANCER DIAGNOSTICS MARKET
FORECAST & OPPORTUNITIES2016 – 2026
https://www.techsciresearch.com/report/asia-pacific-cancer-diagnostics-market/7303.html
-
About Us & Disclaimer
TechSci Research is a global market research and consulting company with offices in the US, UK and India. TechSci Research provides market research reports in number of areas
to organizations. The company uses innovative business Modes that focus on improving productivity, while ensuring creation of high-quality reports. The proprietary forecasting
Modes use various analyses of both industry-specific and macroeconomic variables on a state-by-state basis to produce a unique ‘bottom-up’ Mode of a country, regional and
global industry prospects. Combined with the detailed analysis of company activity and industry trends, the result is a uniquely rich evaluation of the opportunities available in the
market.
Related Reports
• Global Self-monitoring Blood Glucose Market By Type (Type 1, Type 2, Hyperglycemia ,Hypoglycemia), By Frequency (One, Four, Others), By Product
(Glucometer, Software, Test Strips, Lancet), By End-User (Hospital, Personal Care), By Region, Forecast & Opportunities, 2025
• Global Electronic Skin Patches Market By Genetic Information (Cardiovascular Monitoring, Wireless Inpatient Monitoring, Diabetes Management,
Iontophoresis Skin patches, Sweat Sensing), By Material (Silicon Based, Polymer Based and Others), By Technology (Disposable and Reusable), By End
User (Hospitals, Ambulatory Surgical Centers and Others), By Region, Forecast & Opportunities, 2025
The contents of this report are based on information generally available to the public from sources believed to be reliable. No representation is made that it is timely, accurate or
complete. TechSci Research has taken due care and caution in compilation of data as this has been obtained from various sources including which it considers reliable and firsthand.
However, TechSci Research does not guarantee the accuracy, adequacy or completeness of any information and it is not responsible for any errors or omissions or for the results
obtained from the use of such information and especially states that it has no financial liability whatsoever to the subscribers / users of this report. The information herein, together
with all estimates and forecasts, can change without notice. All the figures provided in this document are indicative of relative market size and are strictly for client’s internal
consumption. Usage of the same for purpose other than internal will require prior approval of TechSci Research.
TechSci Research – North America708 Third Avenue, Manhattan,
New York, United States
Tel: +1- 646- 360- 1656
Email: [email protected]
www.techsciresearch.com
Disclaimer
TechSci Research – Europe54, Old brook, Bretton,
Peterborough,
United Kingdom
Email: [email protected]
www.techsciresearch.com
TechSci Research – Asia-PacificB – 44, Sector – 57, Noida, National Capital
Region, U.P. - India
Tel: +91-120-4523900
Email: [email protected]
www.techsciresearch.com